Dr. Cardineau began his career in the field of Agricultural Biotechnology in 1983 as a Scientist at a small start-up company, Sungene Technologies, where he also served a short time as Manager of Market Development. He moved to Agrigenetics in 1989 as Director of Molecular Biology. In 1993 Agrigenetics was acquired by Mycogen Corporation and Dr. Cardineau assumed responsibility as Director for Molecular Biology and Biochemistry. In 1996 he became Director, Technology Development, involved in strategic planning and implementation regarding Intellectual Property and the identification, evaluation and acquisition of technology directed toward future product development. He received the Mycogen President’s Award in 1996 and 1998 for his contributions to the company. Dow AgroSciences acquired Mycogen in 1998 and he returned to research assuming the positions of Global Leader R&D, Output Agriculture Gene Discovery and Site Leader for the San Diego, CA, Research Facility, a four building campus with over 160 research and business related personnel. In 2002 he became Global Leader for Science and Technology with responsibilities involved in strategic research planning. He received a Dow AgroSciences Inventors Award in 1998, 1999, 2000, 2001 and 2002. His laboratory groups contributed to the development of several agricultural biotechnology products in the market place and in commercial development, including Herculex Insect Resistant Corn, Widestrike Cotton and the first transgenic plant made pharmaceutical approved and licensed by a regulatory authority any place in the world, a Newcastle Disease Virus subunit vaccine produced in tobacco cell culture, for which he received a Dow Vision Award in 2006.
In January 2003 he joined Arizona State University with appointments in the Center for Infectious Diseases and Vaccinology of the Biodesign Institute, the School of Life Sciences and the Sandra Day O’Connor College of Law, where he helped to establish several new teaching and entrepreneurial programs, including the Technology Ventures Clinic, providing a transactional experience in technology transfer to students from Law, Business, Engineering and Science curriculums. He served on a team empanelled by the President of ASU to develop a conceptual center for entrepreneurship, which resulted in a proposal to create an “Innovation Institute,” as an original member of Advisory Board of both ASU Technopolis and the University as Entrepreneur Initiative “Student Pathways” and also on the curriculum committee for the Kaufmann Entrepreneurial Campuses Initiative at ASU. He was named as Associated Students of Arizona State University Centennial Professor in April of 2008 for his contributions to teaching and to mentoring his students. In July 2008, Dr. Cardineau retired from ASU and was awarded Emeritus Faculty status by ASU President Michael Crow for his contributions to the University.
He then moved to Tecnologico de Monterrey in August 2008 to be Director of the Centro de Agrobiotecnologia. He served as a Professor in Escuela de Biotecnología y Ciencias de la Salud and Escuela Nacional de Posgrado en Ciencias Ingeniería y Tecnologías, and was the Founding Director of a new undergraduate student program, the Catedra i4, established to promote the development of imagination, investigation, innovation and incubation within the student population of Biotechnology. In a recent survey of ITESM Alumni asked to identify Faculty whose “legacy of knowledge and passion for teaching, were and continue to be important in your professional and personal life,” he has been identified as one of the “Profesores que Dejaron Huella,” or Professors who have left their mark. He is currently a member of CONACyT Sistema Nacional de Investigadores (SNI) and was admitted into the Mexican Academy of Sciences in November 2015 and officially inducted in June 2016.
Dr. Cardineau retired from Tec de Monterrey on May 31, 2016, and returned to the Sandra Day O’Connor College of Law at ASU as an Instructor/Lecturer where he is co-teaching courses related to Biotechnology and Health Technologies, and remains a Faculty Fellow in the Center for Law, Science and Innovation, and also Professor Emeritus at the University.
His academic credentials include a B.A. in American Civilization, a B.S. in Microbiology and a Ph.D. in Molecular and Cellular Biology. He has co-authored over 30 scientific papers, book chapters and a book, and has been included in a number of Who’s Who listings as well as Men and Women of Science. He served on the Science Advisory Board for the County of San Diego, CA, the Advisory Boards of ASU Technopolis and The Technology Ventures Clinic at AzTE, has been a Biotechnology Expert for both the US Grains Council and the Organization of American States, has served as an advisor and consultant to the start-up biotechnology companies ERAbiotech, Algal Technologies and Sonora Transplant, is member of the Flinn Foundation BioAgriculture Research/Technology Platform Committee for Arizona and served the United States Secretary of Agriculture as a member of the Advisory Committee on Biotechnology and 21st Century Agriculture (AC21). He is an inventor of 29 issued and 20 published and pending US patent applications in the plant sciences, with over 140 patents and applications worldwide, including broad enabling patents describing the earliest production of vaccines in transgenic plants, the synthesis of genes to improve their expression in a foreign host and the only plant made vaccine approved by a regulatory authority for commercial release.